Development of COVID-19 vaccine AZD1222 expands into US Phase III clinical trial across all adult age groups

submitted by Pis-dur from astrazeneca-us.com

sorted by:
top
newinsightfulfun
you are viewing a single comment's thread.

view the rest of the comments →

[–][deleted] 2 insightful - 1 fun2 insightful - 0 fun3 insightful - 1 fun -  (2 children)

And a defective virus vaccine properly dosed for children would be bad beeecaaauuuuse....?

[–]chadwickofwv 1 insightful - 1 fun1 insightful - 0 fun2 insightful - 1 fun -  (1 child)

Because it will still kill hundreds of thousands of children. The dosage they will give will kill millions.

[–][deleted] 1 insightful - 1 fun1 insightful - 0 fun2 insightful - 1 fun -  (0 children)

Uh, no? This is a modified defective influenza virus vaccine. If your child was going to be so severely immunocompromised that a flu vaccine would kill it, it should be living in a bubble. Where do you get this crap?